Log in to save to my catalogue

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e944cfc56eb847fd841efdd3279a38db

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy

About this item

Full title

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy

Publisher

Basel: MDPI AG

Journal title

Medicina (Kaunas, Lithuania), 2022-07, Vol.58 (7), p.886

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Background and Objectives: The incidence of urothelial cancer in males is higher than in females; however, females have a higher risk of recurrence and progression. The aim of our study was to report the effect of gender on the oncological outcome in advanced urothelial cancer. Materials and Methods: In our retrospective study, all patients had und...

Alternative Titles

Full title

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e944cfc56eb847fd841efdd3279a38db

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e944cfc56eb847fd841efdd3279a38db

Other Identifiers

ISSN

1648-9144,1010-660X

E-ISSN

1648-9144

DOI

10.3390/medicina58070886

How to access this item